Simon M. N. Efange

1.7k total citations
69 papers, 1.4k citations indexed

About

Simon M. N. Efange is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Simon M. N. Efange has authored 69 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 19 papers in Organic Chemistry. Recurrent topics in Simon M. N. Efange's work include Neuroscience and Neuropharmacology Research (21 papers), Nicotinic Acetylcholine Receptors Study (15 papers) and Receptor Mechanisms and Signaling (11 papers). Simon M. N. Efange is often cited by papers focused on Neuroscience and Neuropharmacology Research (21 papers), Nicotinic Acetylcholine Receptors Study (15 papers) and Receptor Mechanisms and Signaling (11 papers). Simon M. N. Efange collaborates with scholars based in United States, Cameroon and Switzerland. Simon M. N. Efange's co-authors include Stanley M. Parsons, Robert H. Mach, Deborah C. Mash, Kennedy D. Nyongbela, Zhude Tu, Robert J. Boudreau, John Pablo, William J. Weiner, Hank F. Kung and Jeffrey Billings and has published in prestigious journals such as Biochemistry, Scientific Reports and Radiology.

In The Last Decade

Simon M. N. Efange

69 papers receiving 1.4k citations

Peers

Countries citing papers authored by Simon M. N. Efange

Since Specialization

Citations

This map shows the geographic impact of Simon M. N. Efange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon M. N. Efange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon M. N. Efange more than expected).

Fields of papers citing papers by Simon M. N. Efange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon M. N. Efange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon M. N. Efange. The network helps show where Simon M. N. Efange may publish in the future.

Co-authorship network of co-authors of Simon M. N. Efange

This figure shows the co-authorship network connecting the top 25 collaborators of Simon M. N. Efange. A scholar is included among the top collaborators of Simon M. N. Efange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon M. N. Efange. Simon M. N. Efange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spirofused tetrahydroisoquinoline-oxindole hybrids as a novel class of fast acting antimalarial agents with multiple modes of action 2020 ·Scientific Reports ·(unknown), (unknown), (unknown), Lawrence Ayong, Simon M. N. Efange	12
2	Structurally simple synthetic 1, 4-disubstituted piperidines with high selectivity for resistant Plasmodium falciparum 2018 ·BMC Pharmacology and Toxicology ·Moses N. Ngemenya, (unknown), (unknown), Dénis Zofou, Fidele Ntie‐Kang, Simon M. N. Efange	8
3	Antiparasitic Sesquiterpenes from the Cameroonian Spice Scleria striatinux and Preliminary In Vitro and In Silico DMPK Assessment 2017 ·Natural Products and Bioprospecting ·Kennedy D. Nyongbela, Fidele Ntie‐Kang, Thomas R. Hoye, Simon M. N. Efange	3
4	4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies 2016 ·Chemistry Central Journal ·(unknown), Fidele Ntie‐Kang, Moses N. Ngemenya, Zhude Tu, Robert H. Mach, Simon M. N. Efange	3
5	ANTIBACTERIAL AGENTS FROM THE SEEDS OF PEUCEDANUM ZENKERI L. (UMBELLIFERAE) 2010 ·Pakistan Journal of Medical Sciences ·James A. Mbah, Donatien Gatsing, Simon M. N. Efange	3
6	In-vitro antimicrobial activity of Ageratum conyzoides (Linn) on clinical isolates of Helicobacter pylori 2009 ·African Journal of Pharmacy and Pharmacology ·Roland N. Ndip, (unknown), (unknown), Henry Namme Luma, (unknown), Simon M. N. Efange	14
7	Chromaproline and Chromaperidine, nicotine agonists, and Donepezil, cholinesterase inhibitor, enhance performance of memory tasks in ovariectomized rats 2002 ·Pharmacology Biochemistry and Behavior ·Victoria N. Luine, (unknown), Zhude Tu, Simon M. N. Efange	9
8	Morphine-induced spinal cholinergic activation: in vivo imaging with positron emission tomography 2001 ·Pain ·(unknown), (unknown), Joseph R. Tobin, Astrid Chiari, Chuanyao Tong, Zemin Xu, Robert H. Mach, Simon M. N. Efange, Richard L. Ehrenkaufer, James C. Eisenach	15
9	N-(3-iodophenyl)trozamicol (IPHT) and related inhibitors of vesicular acetylcholine transport: synthesis and preliminary biological characterization 1999 ·Nuclear Medicine and Biology ·(unknown), (unknown), Stanley M. Parsons, Robert H. Mach, Simon M. N. Efange	11
10	In Vivo Imaging of the Spinal Cord Cholinergic System with PET 1999 ·Journal of Computer Assisted Tomography ·H. Donald Gage, (unknown), Astrid Chiari, Zemin Xu, Robert H. Mach, Simon M. N. Efange, Richard L. Ehrenkaufer, James C. Eisenach	5
11	Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: In vitro binding studies and positron emission tomography studies in nonhuman primates 1997 ·Synapse ·Robert H. Mach, Mary Lou Voytko, Richard L. Ehrenkaufer, Michael A. Nader, Joseph R. Tobin, Simon M. N. Efange, Stanley M. Parsons, H. Donald Gage, Cynthia R. Smith, Thomas E. Morton	44
12	Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand 1996 ·Nuclear Medicine and Biology ·(unknown), Simon M. N. Efange, G. C. Haidet, Scott McKnite, (unknown), (unknown), (unknown), Keith G. Lurie	6
13	The vesamicol receptor ligand (+)-meta-[1251]iodobenzyltrozamicol {(+)-[125¦]-MIBT} reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: Possible implications for parkinson's disease 1996 ·Life Sciences ·Simon M. N. Efange, (unknown), (unknown), Walter C. Low	13
14	Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands 1995 ·Nuclear Medicine and Biology ·Simon M. N. Efange, (unknown), (unknown)	6
15	Interaction of tetrahydrostilbazoles with monoamine oxidase A and B 1994 ·Journal of Medicinal Chemistry ·S O Sablin, M. Krueger, Thomas P. Singer, С. О. Бачурин, (unknown), Simon M. N. Efange, Sergey E. Tkachenko	11
16	Synthesis and tissue distribution of iodine-125-labeled (m-[125I]iodobenzyl)trozamicol ([125I]MIBT): potential radioligand for mapping central cholinergic innervation 1993 ·Journal of Medicinal Chemistry ·Simon M. N. Efange, (unknown), (unknown), (unknown)	43
17	Nonsymmetrical bipiperidyls as inhibitors of vesicular acetylcholine storage 1993 ·Journal of Medicinal Chemistry ·Simon M. N. Efange, (unknown), Stanley M. Parsons, (unknown), Tobias Metzenthin	22
18	Flexible N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analog: synthesis and monoamine oxidase catalyzed bioactivation 1990 ·Journal of Medicinal Chemistry ·Simon M. N. Efange, (unknown), Rory P. Remmel, Robert J. Boudreau, Aloke K. Dutta, (unknown)	30
19	Selective Visualization of Rodent Locus Ceruleus by a Radiolabeled N‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Analog 1989 ·Journal of Neurochemistry ·Simon M. N. Efange, Deborah C. Mash, Franz Hefti, Hank F. Kung, Jeffrey Billings	3
20	Synthesis and biodistribution of 99mTc-labeled piperidinyl bis(aminoethanethiol) complexes: potential brain perfusion imaging agents for single photon emission computed tomography 1988 ·Journal of Medicinal Chemistry ·Simon M. N. Efange, Hank F. Kung, Jeffrey Billings, Monte Blau	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact